The following is the latest COVID-19 information from the federal government as of 2:30 p.m. on Tuesday, November 10.

Food and Drug Administration

Department of Health and Human Services

  • HHS has announced plans to allocate initial doses of the investigational monoclonal antibody therapeutic bamlanivimab. Beginning immediately, weekly allocations to state and territorial health departments will be proportionally based on confirmed COVID-19 cases in each state and territory over the previous seven days based on data hospitals and state health departments enter into the HHS Protect data collection platform.  States will then decide on its distribution, with possible locations including hospital outpatient facilities, hospital emergency departments, and alternate care sites set up by hospitals and health departments.  These government-purchased doses will be available at no cost to patients, although health care facilities could charge for administering the medicine.  Learn more about the allocation and distribution processes here and find the week one allocation dashboard here.

Centers for Medicare & Medicaid Services

CMS COVID-19 Stakeholder Calls 

CMS hosts varied recurring stakeholder engagement sessions to share information related to the agency’s response to COVID-19.  These sessions are open to members of the health care community and are intended to provide updates, share best practices among peers, and offer attendees an opportunity to ask questions of CMS and other subject matter experts.

CMS COVID-19 Office Hours Call

Tuesday, November 17 at 5:00 – 6:00 PM (eastern)

Toll Free Attendee Dial In:  833-614-0820

Access Passcode:  2491556

Audio Webcast link:  go here


Wednesday, November 18 at 4:30 – 5:00 PM (eastern)

Toll Free Attendee Dial-In:  833-614-0820

Access Passcode:  1335116

Audio Webcast link:  go here

Centers for Disease Control and Prevention

National Institutes of Health

Department of Labor